Related Experiment Video

Updated: Apr 23, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

10.3K

Chemical biology tools for regulating RAS signaling complexity in space and time

Hilde van Hattum1, Herbert Waldmann2

  • 1Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.

Chemistry & Biology
|September 20, 2014
PubMed

Insights

Targeting mutated Rat sarcoma (RAS) proteins in cancer is crucial. This review explores innovative chemical biology strategies, including novel binding pockets and covalent inhibitors, to control RAS signaling and develop new cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Chemical Biology

Background:

  • Rat sarcoma (RAS) proteins are small GTPases vital for cellular proliferation.
  • Mutated RAS proteins are prevalent in human tumors, leading to deregulated signaling and uncontrolled cell growth.
  • Current therapeutic strategies for RAS-driven cancers remain limited.

Purpose of the Study:

  • To review the role of RAS proteins in cellular signaling and cancer.
  • To discuss innovative chemical biology approaches for targeting RAS signaling pathways.
  • To highlight the potential of small molecule probes in developing clinical cancer drugs.

Main Methods:

  • Literature review of RAS signaling pathways and cancer relevance.
  • Exploration of chemical biology strategies for RAS modulation.
  • Discussion of newly identified binding pockets and covalent inhibitors.

Main Results:

  • RAS signaling is a key driver in a significant portion of human cancers.
  • Small molecule probes offer precise control over RAS signaling in space and time.
  • Targeting mutated RAS, particularly through covalent inhibition and localization impairment, shows therapeutic promise.

Conclusions:

  • Developing effective small molecule inhibitors for mutated RAS is a critical unmet need in oncology.
  • Innovative chemical biology approaches provide new avenues for RAS-targeted cancer therapy.
  • Translating insights from chemical biology probes into clinically useful drugs is essential for improving patient outcomes.

More Related Videos

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

1.2K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

2.3K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

2.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
4.7K